Published in Gynecol Endocrinol on September 01, 2010
Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol (2012) 0.97
Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. J Assist Reprod Genet (2013) 0.77
Insulin receptor substrate-1 (IRS-1) rs1801278G>A polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Prevalence of the insulin receptor substrate-1(IRS-1) Gly972Arg and the insulin receptor substrate-2(IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy women. J Assist Reprod Genet (2011) 0.75
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril (2006) 2.22
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem (2005) 1.62
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
General Practice as a career choice among undergraduate medical students in Greece. BMC Med Educ (2007) 1.47
Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod (2005) 1.43
Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis. Free Radic Biol Med (2007) 1.34
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27
Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab (2008) 1.27
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26
Exercise and the stress system. Hormones (Athens) (2006) 1.24
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab (2010) 1.24
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) (2007) 1.18
Diagnosing arthrogryposis multiplex congenita: a review. ISRN Obstet Gynecol (2012) 1.18
Development of leiomyomas on the uterine remnants of two women with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril (2004) 1.14
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12
Metabolic syndrome and polycystic ovary syndrome... and vice versa. Arq Bras Endocrinol Metabol (2009) 1.10
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod (2006) 1.10
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08
Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. Eur J Endocrinol (2008) 1.05
The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev (2004) 1.05
Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol (2008) 1.02
Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci (2006) 1.01
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01
Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care (2006) 1.01
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab (2012) 1.00
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod (2011) 1.00
Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults". Clin Chem (2008) 1.00
Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2005) 0.99
Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99
Cell-free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining. Clin Chem (2006) 0.98
Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril (2006) 0.98
Fetal growth restriction and postnatal development. Ann N Y Acad Sci (2006) 0.98
Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab (2010) 0.98
Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond Engl) (2008) 0.97
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem (2007) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis (2010) 0.95
Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod (2008) 0.95
Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol (2012) 0.95
The role of stress in female reproduction and pregnancy: an update. Ann N Y Acad Sci (2010) 0.95
Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens) (2006) 0.95
Thyroid volume and echostructure in schoolchildren living in an iodine-replete area: relation to age, pubertal stage, and body mass index. Thyroid (2007) 0.94
Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol (2010) 0.94
Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. Eur J Contracept Reprod Health Care (2007) 0.93
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2008) 0.93
Menstrual disorders. Endocr Dev (2012) 0.93
Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. J Bone Miner Metab (2010) 0.93
Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril (2008) 0.93
Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. Exp Diabetes Res (2012) 0.93
Liver failure due to antithyroid drugs: report of a case and literature review. Endocrine (2010) 0.92
Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci (2003) 0.92
PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) (2011) 0.91
Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis (2006) 0.91
The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol (2009) 0.91
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90
Direct detection of unamplified DNA from pathogenic mycobacteria using DNA-derivatized gold nanoparticles. J Microbiol Methods (2009) 0.90
Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol (2007) 0.90
Complexity and non-linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation. Endocr Regul (2002) 0.90
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia. Gynecol Endocrinol (2010) 0.90
Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr Diabetes Rev (2010) 0.90
Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs (2006) 0.90
HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89
Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol (2005) 0.89
The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab (2012) 0.89
Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractions. Am J Obstet Gynecol (2006) 0.89
The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem (2007) 0.89
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril (2002) 0.89
The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development. Endocrine (2007) 0.89